Login / Signup

Combination of omalizumab and bee venom immunotherapy: does it work?

İnsu YılmazSakine Nazik BahçecioğluMurat Türk
Published in: Asia Pacific allergy (2018)
Bee venom immunotherapy (b-VIT) can be combined with omalizumab therapy in order to suppress systemic reactions developing due to b-VIT itself. Omalizumab acts as a premedication and gains time for the immunotherapy to develop its immunomodulatory effects. However, the combination of omalizumab and b-VIT is not always effective enough. Herein we present a patient in whom successful immunotherapy cannot be achieved with combination of omalizumab to b-VIT.
Keyphrases
  • case report
  • mesenchymal stem cells
  • cell therapy
  • smoking cessation